Heydari Mohammadbagher, Saifi Mehrdad, Ghanbari-Movahed Maryam, Salari Nader, Faghihi Sayed Hassan, Mohammadi Masoud
Department of General Surgery, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Medical Technology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Arch Dermatol Res. 2025 Jan 20;317(1):301. doi: 10.1007/s00403-025-03817-8.
Skin cancer is the commonest malignancy for the population. Conventional skin cancer treatments include chemotherapy and surgery, but a large number of the chemotherapeutic drugs applied currently have undesirable possessions. The aim of this study is to provide a complete and acute assessment of the antitumor capability of gold nano-formulations in skin cancer as a new and more effectual delivery system for targeted therapy. In this systematic review, we conducted our first search in December 2021. In order to find related studies, 3 databases PubMed, Scopus and ScienceDirect. In order to maintain comprehensiveness in the search, no time limit was considered in the search process and finally the information obtained from the search was transferred to the information management software (EndNote). In order to maximize the number of articles that were related to our topic, a list of references identified in relevant articles was also manually searched and reviewed. Our final search was updated in late December 2021. There was evidence for a correlation between anticancer activities and treatment with gold nano-formulations. Additionally, studies shown that specific functionalization of the gold nanoparticles (Au NPs) which increase targetability to specific populations of cells could increase the application of Au NPs to the effective delivery of drugs to tumor cells. Our study demonstrated that gold nano-formulations are possible candidates for skin cancer treatment and might provide additional support for the clinical use of these anticancer agents in the future.
皮肤癌是人群中最常见的恶性肿瘤。传统的皮肤癌治疗方法包括化疗和手术,但目前应用的大量化疗药物都有不良作用。本研究的目的是对金纳米制剂在皮肤癌中的抗肿瘤能力进行全面而敏锐的评估,金纳米制剂是一种新型且更有效的靶向治疗递送系统。在这项系统评价中,我们于2021年12月进行了首次检索。为了查找相关研究,检索了3个数据库,即PubMed、Scopus和ScienceDirect。为了在检索中保持全面性,检索过程中未设定时间限制,最后将检索获得的信息转移至信息管理软件(EndNote)。为了最大限度地增加与我们主题相关的文章数量,还手动搜索并审查了相关文章中确定的参考文献列表。我们的最终检索于2021年12月底更新。有证据表明抗癌活性与金纳米制剂治疗之间存在关联。此外,研究表明,金纳米颗粒(Au NPs)的特定功能化可增加对特定细胞群体的靶向性,从而可增加Au NPs在将药物有效递送至肿瘤细胞方面的应用。我们的研究表明,金纳米制剂可能是皮肤癌治疗的候选药物,并可能为这些抗癌药物未来的临床应用提供额外支持。